CooperCompanies (NYSE: COO) has announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics, and gynecology markets. Cooper will pay approximately US$875 million comprised of US$675 million at closing and US$200 million paid in four US$50 million annual installments.

Latham & Watkins LLP represents CooperCompanies in the transaction with a corporate deal team led by Bay Area partners Tad Freese and Mark Bekheit, with Bay Area associates Brad Alvarez, Sally Wong, and Langston Tolbert. Advice was also provided on benefits and compensation matters by Bay Area partner James Metz, with Washington, D.C. associate Ashlie Lawton; on data and technology transactions by Bay Area partner Anthony Klein, with Bay Area associate Fiona Gillan; on healthcare and life sciences related matters by Bay Area partner Jekkie Kim, with Bay Area associate Billy Wu; on tax matters by Bay Area partner Grace Lee, with Bay Area associate Derek Gumm; on data privacy matters by Bay Area counsel Heather Deixler, with Los Angeles associate Heather Lui and London associate Mihail Krepchev; on healthcare regulatory matters by Bay Area counsel Betty Pang, with Los Angeles associate Leia Gu; on FDA regulatory matters by Washington, D.C. partner Elizabeth Richards, with Washington, D.C. associates Nathan Beaton and Daniel Machado; on European regulatory matters by Paris/Brussels partner Eveline Van Keymeulen, with London associate Ranulf Barman; on export control matters by Washington, D.C. partner Erin Brown Jones, with Washington, D.C. associate Erin Eckles; on antitrust matters by Washington, D.C. partners Mandy Reeves and Ian Conner and Brussels partner Hector Armengod and Washington, D.C. counsel Peter Todaro, with Bay Area associate Silvia Segade Sanz and Brussels associates Anthemis Economou and Stergos Chatzidiakos; on labor matters by Chicago partner Nineveh Alkhas, Munich partner Tobias Leder and Paris partner Matthias Rubner, with Chicago associate Laura Waller and Paris associates Celia Gallo and Leo Theillac; and on other litigation-related matters by Washington, D.C. counsel Andrew Galdes, with Washington, D.C. associate Asia Cadet.

The firm also recently advised CooperCompanies in the acquisition of Generate Life Sciences which closed in December 2021.